documents: FDA-2014-D-1891-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2014-D-1891-0001 FDA FDA-2014-D-1891 How To Obtain a Letter From the Food and Drug Administration Stating That Bioequivalence Study Protocols Contain Safety Protections Comparable to Applicable Risk Evaluation and Mitigation Strategies for Reference Listed Drugs; Draft Guidance for Industry; Availability Notice Notice of Availability 2014-12-05T05:00:00Z 2014 12 2014-12-05T05:00:00Z 2015-02-04T04:59:59Z 2020-04-23T19:23:52Z 2014-28540 0 0 090000648195e613

Links from other tables